Licensed journals
The FID Pharmazie is licensing academic journals and offers full-text access to pharmaceutical scientists in Germany. The journals can be directly accessed, without registration, via the network of certain academic institutions (following the list of eligible institutions, and universities).
Additionally, there is a limited license contingent for scientists from other public institutions. Please, contact us if you are interested!
All journal articles licensed by FID Pharmazie are available via PubPharm.
Thomson Reuters / Clarivate Analytics
* Publication of the journals was discontinued in 2023. The archive volumes are currently accessible via "Portico" (www.portico.org).
Avoxa
- Die Pharmazie: An International Journal of Pharmaceutical Sciences (from 2003) (OA-Transformation 2020)
Taylor & Francis
These journals are available from 1997 or starting with the first volume if publication started after 1997:
- Bioanalysis
- Drug and Chemical Toxicology (2015-2018)
- Drug Delivery
- Drug Development and Industrial Pharmacy
- Drug Metabolism Reviews
- Expert Opinion on Drug Delivery
- Expert Opinion on Drug Safety
- Expert Opinion on Emerging Drugs
- Expert Opinion on Investigational Drugs
- Future Medicinal Chemistry
- Journal of Biopharmaceutical Statistics
- Journal of Dietary Supplements (2015-2018)
- Journal of Drug Targeting
- Journal of Essential Oil Research: JEOR
- Journal of Herbs, Spices & Medicinal Plants
- Journal of Microencapsulation
- Nanomedicine
- Pharmaceutical Biology
- Pharmaceutical Development and Technology
- Pharmacogenomics
- Therapeutic Delivery
- Xenobiotica (2015-2018)
Bentham
These journals are available from 2010:
- Anti-Cancer Agents in Medicinal Chemistry
- Anti-Infective Agents
- Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Cardiovascular & Hematological Agents in Medicinal Chemistry
- Cardiovascular & Hematological Disorders-Drug Targets
- Central Nervous System Agents in Medicinal Chemistry
- CNS & Neurological Disorders – Drug Targets
- Combinatorial Chemistry & High Throughput Screening
- Current Bioactive Compounds
- Current Cancer Drug Targets
- Current Computer Aided-Drug Design
- Current Drug Delivery
- Current Drug Discovery Technologies
- Current Drug Metabolism
- Current Drug Safety
- Current Drug Targets
- Current Drug Therapy
- Current Medicinal Chemistry
- Current Molecular Pharmacology
- Current Neuropharmacology
- Current Pharmaceutical Analysis
- Current Pharmaceutical Biotechnology
- Current Pharmaceutical Design
- Current Pharmacogenomics and Personalized Medicine
- Current Topics in Medicinal Chemistry
- Endocrine, Metabolic & Immune Disorders – Drug Targets (from 2010)
- Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry (2010-2018)
- Medicinal Chemistry
- Mini-Reviews in Medicinal Chemistry
- Recent Advances in Drug Delivery and Formulation (formerly: Recent Patents on Drug Delivery & Formulation)
In alphabetical order
- Anti-Cancer Agents in Medicinal Chemistry (from 2010) (Bentham)
- Anti-Infective Agents (from 2010) (Bentham)
- Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (from 2010) (Bentham)
- Bioanalysis (all Volumes) (Taylor & Francis / formerly Future Science)
- Cardiovascular & Hematological Agents in Medicinal Chemistry (from 2010) (Bentham)
- Cardiovascular & Hematological Disorders-Drug Targets (from 2010) (Bentham)
- Central Nervous System Agents in Medicinal Chemistry (from 2010) (Bentham)
- CNS & Neurological Disorders – Drug Targets (from 2010) (Bentham)
- Combinatorial Chemistry & High Throughput Screening (from 2010) (Bentham)
- Current Bioactive Compounds (from 2010) (Bentham)
- Current Cancer Drug Targets (from 2010) (Bentham)
- Current Computer Aided-Drug Design (from 2010) (Bentham)
- Current Drug Delivery (from 2010) (Bentham)
- Current Drug Discovery Technologies (from 2010) (Bentham)
- Current Drug Metabolism (from 2010) (Bentham)
- Current Drug Safety (from 2010) (Bentham)
- Current Drug Targets (from 2010) (Bentham)
- Current Drug Therapy (from 2010) (Bentham)
- Current Medicinal Chemistry (from 2010) (Bentham)
- Current Molecular Pharmacology (from 2010) (Bentham)
- Current Neuropharmacology (from 2010) (Bentham)
- Current Pharmaceutical Analysis (from 2010) (Bentham)
- Current Pharmaceutical Biotechnology (from 2010) (Bentham)
- Current Pharmaceutical Design (from 2010) (Bentham)
- Current Pharmacogenomics and Personalized Medicine (from 2010) (Bentham)
- Current Topics in Medicinal Chemistry (from 2010) (Bentham)
- Die Pharmazie: An International Journal of Pharmaceutical Sciences (from 2003) (Avoxa) (OA-Transformation 2020)
- Drug and Chemical Toxicology (2015-2018) (Taylor & Francis)
- Drug Delivery (from 1997) (Taylor & Francis)
- Drug Development and Industrial Pharmacy (from 1997) (Taylor & Francis)
- Drug Metabolism Reviews (from 1997) (Taylor & Francis)
- Drugs of the Future (1998-2023) (Thomson Reuters / Clarivate Analytics)
- Drugs of Today (1998-2023) (Thomson Reuters / Clarivate Analytics)
- Endocrine, Metabolic & Immune Disorders – Drug Targets (from 2010) (Bentham)
- Expert Opinion on Drug Delivery (from 2004) (Taylor & Francis)
- Expert Opinion on Drug Safety (from 2002) (Taylor & Francis)
- Expert Opinion on Emerging Drugs (from 2001) (Taylor & Francis)
- Expert Opinion on Investigational Drugs (from 1997) (Taylor & Francis)
- Future Medicinal Chemistry (all Volumes) (Taylor & Francis / formerly Future Science)
- Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry (2010-2018) (Bentham)
- Journal of Biopharmaceutical Statistics (from 1997) (Taylor & Francis)
- Journal of Dietary Supplements (2015-2018) (Taylor & Francis)
- Journal of Drug Targeting (from 1997) (Taylor & Francis)
- Journal of Essential Oil Research: JEOR (from 1997) (Taylor & Francis)
- Journal of Herbs, Spices & Medicinal Plants (from 1997) (Taylor & Francis)
- Journal of Microencapsulation (from 1997) (Taylor & Francis)
- Medicinal Chemistry (from 2010) (Bentham)
- Mini-Reviews in Medicinal Chemistry (from 2010) (Bentham)
- Nanomedicine (all Volumes) (Taylor & Francis / formerly Future Science)
- Pharmaceutical Biology (from 1997) (Taylor & Francis)
- Pharmaceutical Development and Technology (from 1997) (Taylor & Francis)
- Pharmacogenomics (all Volumes) (Taylor & Francis / formerly Future Science)
- Pharmazeutische Industrie (from 2009) (Edito Cantor)
- Recent Advances in Drug Delivery and Formulation (formerly: Recent Patents on Drug Delivery & Formulationon) (from 2010) (Bentham)
- TechnoPharm (all Volumes) (Editio Cantor)
- Therapeutic Delivery (all Volumes) (Taylor & Francis / formerly Future Science)
- Xenobiotica (2015-2018) (Taylor & Francis)
Pharmaceutical Chemistry
- Anti-Cancer Agents in Medicinal Chemistry (from 2010) (Bentham)
- Anti-Infective Agents (from 2010) (Bentham)
- Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (from 2010) (Bentham)
- Bioanalysis (all Volumes) (Taylor & Francis / formerly Future Science)
- Cardiovascular & Hematological Agents in Medicinal Chemistry (from 2010) (Bentham)
- Cardiovascular & Hematological Disorders-Drug Targets (from 2010) (Bentham)
- Central Nervous System Agents in Medicinal Chemistry (from 2010) (Bentham)
- CNS & Neurological Disorders – Drug Targets (from 2010) (Bentham)
- Combinatorial Chemistry & High Throughput Screening (from 2010) (Bentham)
- Current Bioactive Compounds (from 2010) (Bentham)
- Current Cancer Drug Targets (from 2010) (Bentham)
- Current Computer Aided-Drug Design (from 2010) (Bentham)
- Current Drug Discovery Technologies (from 2010) (Bentham)
- Current Drug Targets (from 2010) (Bentham)
- Current Medicinal Chemistry (from 2010) (Bentham)
- Current Pharmaceutical Analysis (from 2010) (Bentham)
- Current Pharmaceutical Design (from 2010) (Bentham)
- Current Topics in Medicinal Chemistry (from 2010) (Bentham)
- Die Pharmazie: An International Journal of Pharmaceutical Sciences (from 2003) (Avoxa) (OA-Transformation 2020)
- Drugs of the Future (1998-2023) (Thomson Reuters / Clarivate Analytics)
- Drugs of Today (1998-2023) (Thomson Reuters / Clarivate Analytics)
- Future Medicinal Chemistry (all Volumes) (Taylor & Francis / formerly Future Science)
- Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry (2010-2018) (Bentham)
- Journal of Biopharmaceutical Statistics (from 1997) (Taylor & Francis)
- Journal of Essential Oil Research: JEOR (from 1997) (Taylor & Francis)
- Medicinal Chemistry (from 2010) (Bentham)
- Mini-Reviews in Medicinal Chemistry (from 2010) (Bentham)
Pharmaceutical Technology
- Current Drug Delivery (from 2010) (Bentham)
- Die Pharmazie: An International Journal of Pharmaceutical Sciences (from 2003) (Avoxa) (OA-Transformation 2020)
- Drug Delivery (from 1997) (Taylor & Francis)
- Drug Development and Industrial Pharmacy (from 1997) (Taylor & Francis)
- Expert Opinion on Drug Delivery (from 2004) (Taylor & Francis)
- Journal of Biopharmaceutical Statistics (from 1997) (Taylor & Francis)
- Journal of Drug Targeting (from 1997) (Taylor & Francis)
- Journal of Microencapsulation (from 1997) (Taylor & Francis)
- Nanomedicine (all Volumes) (Taylor & Francis / formerly Future Science)
- Pharmaceutical Development and Technology (from 1997) (Taylor & Francis)
- Pharmazeutische Industrie (from 2009) (Edito Cantor)
- Recent Advances in Drug Delivery and Formulation (formerly: Recent Patents on Drug Delivery & Formulation) (from 2010) (Bentham)
- TechnoPharm (all Volumes) (Editio Cantor)
- Therapeutic Delivery (all Volumes) (Taylor & Francis / formerly Future Science)
Pharmaceutical Biology
- Bioanalysis (all Volumes) (Taylor & Francis / formerly Future Science)
- Cardiovascular & Hematological Disorders-Drug Targets (from 2010) (Bentham)
- CNS & Neurological Disorders – Drug Targets (from 2010) (Bentham)
- Combinatorial Chemistry & High Throughput Screening (from 2010) (Bentham)
- Current Bioactive Compounds (from 2010) (Bentham)
- Current Cancer Drug Targets (from 2010) (Bentham)
- Current Pharmaceutical Biotechnology (from 2010) (Bentham)
- Current Pharmacogenomics and Personalized Medicine (from 2010) (Bentham)
- Die Pharmazie: An International Journal of Pharmaceutical Sciences (from 2003) (Avoxa) (OA-Transformation 2020)
- Journal of Biopharmaceutical Statistics (from 1997) (Taylor & Francis)
- Journal of Dietary Supplements (2015-2018) (Taylor & Francis)
- Journal of Essential Oil Research: JEOR (from 1997) (Taylor & Francis)
- Journal of Herbs, Spices & Medicinal Plants (from 1997) (Taylor & Francis)
- Pharmaceutical Biology (from 1997) (Taylor & Francis)
- Pharmacogenomics (all Volumes) (Taylor & Francis / formerly Future Science)
Pharmacology / Clinical Pharmacy
- Anti-Infective Agents (from 2010) (Bentham)
- Cardiovascular & Hematological Disorders-Drug Targets (from 2010) (Bentham)
- CNS & Neurological Disorders – Drug Targets (from 2010) (Bentham)
- Current Bioactive Compounds (from 2010) (Bentham)
- Current Cancer Drug Targets (from 2010) (Bentham)
- Current Drug Metabolism (from 2010) (Bentham)
- Current Drug Safety (from 2010) (Bentham)
- Current Drug Targets (from 2010) (Bentham)
- Current Drug Therapy (from 2010) (Bentham)
- Current Molecular Pharmacology (from 2010) (Bentham)
- Current Neuropharmacology (from 2010) (Bentham)
- Current Pharmaceutical Analysis (from 2010) (Bentham)
- Current Pharmacogenomics and Personalized Medicine (from 2010) (Bentham)
- Die Pharmazie: An International Journal of Pharmaceutical Sciences (from 2003) (Avoxa) (OA-Transformation 2020)
- Drug and Chemical Toxicology (2015-2018) (Taylor & Francis)
- Drug Metabolism Reviews (from 1997) (Taylor & Francis)
- Drugs of the Future (1998-2023) (Thomson Reuters / Clarivate Analytics)
- Drugs of Today (1998-2023) (Thomson Reuters / Clarivate Analytics)
- Endocrine, Metabolic & Immune Disorders – Drug Targets (from 2010) (Bentham)
- Expert Opinion on Drug Safety (from 2002) (Taylor & Francis)
- Expert Opinion on Emerging Drugs (from 2001) (Taylor & Francis)
- Expert Opinion on Investigational Drugs (from 1997) (Taylor & Francis)
- Journal of Biopharmaceutical Statistics (from 1997) (Taylor & Francis)
- Journal of Dietary Supplements (2015-2018) (Taylor & Francis)
- Journal of Essential Oil Research: JEOR (from 1997) (Taylor & Francis)
- Nanomedicine (all Volumes) (Taylor & Francis / formerly Future Science)
- Pharmaceutical Biology (from 1997) (Taylor & Francis)
- Pharmacogenomics (all Volumes) (Taylor & Francis / formerly Future Science)
- Therapeutic Delivery (all Volumes) (Taylor & Francis / formerly Future Science)
- Xenobiotica (2015-2018) (Taylor & Francis)
Eligible institutions for FID licenses
Scientists and staff members from pharmaceutical institutes at one of the below 22 universities in Germany, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and TU Dortmund are eligible users for FID licenses. Additionally, scientists from other institutions can register for an individual account.
Hereafter is the list of the 24 eligible locations where direct access to the FID licenses should be available via their network.
You are not an eligible user but are interested in the licensed journals? Full texts of all articles can be ordered via inter-library loan. Additionally, a limited license contingent for scientists from other public institutions is available. If you have questions, contact us.
Location of pharmaceutical institutes
| Location | Name of institution |
| Berlin | Freie Universität |
| Bonn | Rheinische Friedrich-Wilhelms-Universität |
| Braunschweig | Technische Universität Carolo Wilhelmina |
| Dortmund | Technische Universität Dortmund |
| Düsseldorf | Heinrich Heine Universität |
| Erlangen-Nürnberg | Friedrich-Alexander-Universität |
| Frankfurt (Main) | Johann-Wolfgang-Goethe-Universität |
| Freiburg | Albert-Ludwigs-Universität |
| Greifswald | Ernst-Moritz-Arndt-Universität |
| Halle | Martin-Luther-Universität Halle-Wittenberg |
| Hamburg | Universität Hamburg |
| Heidelberg | Ruprecht-Karls-Universität |
| Jena | Friedrich-Schiller-Universität |
| Kiel | Christian-Albrechts-Universität |
| Leipzig | Universität Leipzig |
| Mainz | Johannes Gutenberg-Universität |
| Marburg | Philipps-Universität |
| München | Ludwig-Maximilians-Universität |
| Münster | Westfälische Wilhelms-Universität |
| Regensburg | Universität Regensburg |
| Saarbrücken | Universität des Saarlandes |
| Tübingen | Eberhard-Karls-Universität |
| Würzburg | Julius-Maximilians-Universität |
| Saarbrücken | Helmholtz-Institut für Pharmazeutische Forschung Saarland |